DAY TWO: Sunday, April 29
8:30 a.m. to 10:00 p.m.
IV. THERAPEUTICS (continued)
Summary of Day 1
Art McCullough
Anti-fibrinolytics
Bruce Runyon
rFVIIa (Recombinent Activated Factor VII)
K Rajender Reddy
Prophylactic versus Rescue RX
Carl Berg
PANEL DISCUSSION
V. COAGULOPATHY
IN FULMINANT LIVER FAILURE
Coagulopathy in FHF
Santiago Munoz
ICP Monitors: Overview
Todd Stravitz
ICP Monitor Placement
Andreas Kramer
Extracorporeal Liver Assist Devices
Rasheed Balogun
PANEL DISCUSSION
VI. TESTS
OF COAGULATION IN LIVER DISEASE: Armando Tripodi
The PT and INR in Liver Disease
O. Chazouilleres
Tests of Fibrinolysis
B. Gail Macik
LUNCH BREAK
VI. TESTS
OF COAGULATION IN LIVER DISEASE (continued)
Platelet Function Testing
Don Gabriel
Thromboelastography
Herman Hendriks
Endothelial Function Testing
Frank Leebeek
PANEL DISCUSSION
VII. SPECIAL
SITUATIONS
Gastric Antral Vascular Ectasia (GAVE)
AMO Al-Osaimi
Gastric Varices
Bimaljit Sandhu
VIII. HYPERCOAGULATION
IN LIVER DISEASE
PAI-1 in Chronic Liver Disease
Gavin Arteel
Anti-Phospholipid and Liver Disease
Emanuelo Albano
Parenchymal Extinction: Histological
Yoshihiro Ikura
Parenchymal Extinction: Clinical
Dr. Quentin Anstee BSC(Hons), MB BS, MRCP(UK)
Imperial College London
Portal Vein Thrombosis
Paulo Bittencourt
Budd-Chiari Syndrome
Patrick Northup
VOD, Defibrotide
Laurie DeLeve
SUMMARY AND
FUTURE DIRECTIONS
SH Caldwell/AJ Sanyal
DINNER AT LOCAL
VINEYARD
